Table 3.
Summary of baseline-Adjusted Subject Mean (SE) for Polymorphonuclear (PMN), Gingival and Plaque Index, Gingival and Plaque Severity, Gingival and Plaque Interproximal scores at the one-week post-treatment evaluation for subjects who completed the entire study.
| Parameter | Treatment | Adj. 1 Week Mean (S.E.) | Within treatment comparisonsa | Between treatment comparisonsb |
|---|---|---|---|---|
| PMN leukocytes (log10Count/ml) | Test | 5.235 (0.008) | 40.7% | 35.9% |
| Control | 5.428 (0.008) | 7.5% | ||
| Gingival Index | Test | 1.15 (0.01) | 21.8% | 15.4% |
| Control | 1.36 (0.01) | 6.8% | ||
| Plaque Index | Test | 1.96 (0.05) | 25.8% | 15.9% |
| Control | 2.33 (0.05) | 12.1% | ||
| Gingival Severity | Test | 0.20 (0.01) | 45.9% | 37.5% |
| Control | 0.32 (0.01) | 15.8% | ||
| Plaque Severity | Test | 0.22 (0.02) | 47.6% | 31.3% |
| Control | 0.32 (0.02) | 21.4% | ||
| Gingival Interproximal | Test | 1.20 (0.01) | 18.9% | 11.8% |
| Control | 1.36 (0.01) | 7.5% | ||
| Plaque Interproximal | Test | 2.01 (0.05) | 25.0% | 15.5% |
| Control | 2.38 (0.05) | 11.2% |
a
Percent change exhibited by the one week mean relative to the baseline mean. A positive value indicates a reduction in the parameter by paired t-test. Statistically significant at p < 0.001.
b
Percent differences between the test and control treatments evaluated by ANCOVA utilizing baseline-adjusted means. Statistically significant at p < 0.001.